Edward Nash
Stock Analyst at Canaccord Genuity
(4.91)
# 239
Out of 4,516 analysts
383
Total ratings
53.3%
Success rate
28.8%
Average return
Main Sectors:
Stocks Rated by Edward Nash
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Maintained: Buy | $107 | $37.97 | +181.80% | 8 | Jul 15, 2026 | |
| RANI Rani Therapeutics Holdings | Maintained: Buy | $5 | $0.649 | +670.42% | 17 | Jul 10, 2026 | |
| CORT Corcept Therapeutics | Maintained: Buy | $135 | $90.47 | +49.22% | 54 | Jul 9, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $56 | $57.06 | -1.86% | 38 | Jul 7, 2026 | |
| CNTB Connect Biopharma Holdings | Maintained: Buy | $6 | $2.36 | +154.78% | 3 | Jun 30, 2026 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $106 → $129 | $112.08 | +15.10% | 4 | Jun 26, 2026 | |
| APGE Apogee Therapeutics | Downgraded: Hold | $130 → $135 | $133.96 | +0.86% | 15 | Jun 23, 2026 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Reiterated: Buy | $11.24 | $1.63 | +589.37% | 24 | May 19, 2026 | |
| VERU Veru Inc. | Rated: Buy | $25 | $2.31 | +982.25% | 3 | May 14, 2026 | |
| PLRX Pliant Therapeutics | Maintained: Hold | $3 | $1.09 | +175.23% | 15 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 | $7.76 | +531.85% | 11 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $38.17 | +62.43% | 11 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $50.59 | +99.64% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $587 → $578 | $536.86 | +7.66% | 40 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $62 → $64 | $61.98 | +3.26% | 3 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $4.40 | +354.55% | 14 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $4.83 | n/a | 8 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $4.00 | n/a | 6 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $15 | $0.5113 | n/a | 15 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $1 | $0.000001 | n/a | 2 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $4.09 | n/a | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $11 | $31.49 | n/a | 7 | Aug 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 | $2.01 | n/a | 1 | Jun 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $39 | $6.13 | n/a | 9 | May 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $176 | $17.96 | n/a | 15 | Feb 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $64 | $41.52 | n/a | 2 | Feb 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $126 → $117 | $58.64 | n/a | 14 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $71 | $32.03 | n/a | 11 | Jan 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $156 | $62.51 | n/a | 1 | Sep 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $132 | $859.43 | n/a | 1 | Sep 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $22 → $4 | $15.47 | n/a | 3 | Jun 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $11.26 | n/a | 1 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $23 | $7.06 | n/a | 2 | May 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $0.0001 | n/a | 1 | Sep 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $2 | $0.0001 | n/a | 2 | May 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $6 | $3.72 | n/a | 8 | May 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $14.69 | n/a | 3 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $11 | $3.98 | n/a | 3 | Sep 4, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.08 | n/a | 1 | Jun 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $13.14 | n/a | 2 | May 3, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $25.49 | n/a | 1 | Jan 28, 2013 |
Viking Therapeutics
Jul 15, 2026
Maintained: Buy
Price Target: $107
Current: $37.97
Upside: +181.80%
Rani Therapeutics Holdings
Jul 10, 2026
Maintained: Buy
Price Target: $5
Current: $0.649
Upside: +670.42%
Corcept Therapeutics
Jul 9, 2026
Maintained: Buy
Price Target: $135
Current: $90.47
Upside: +49.22%
Travere Therapeutics
Jul 7, 2026
Maintained: Buy
Price Target: $56
Current: $57.06
Upside: -1.86%
Connect Biopharma Holdings
Jun 30, 2026
Maintained: Buy
Price Target: $6
Current: $2.36
Upside: +154.78%
Kymera Therapeutics
Jun 26, 2026
Reiterated: Buy
Price Target: $106 → $129
Current: $112.08
Upside: +15.10%
Apogee Therapeutics
Jun 23, 2026
Downgraded: Hold
Price Target: $130 → $135
Current: $133.96
Upside: +0.86%
Cardiol Therapeutics Inc.
May 19, 2026
Reiterated: Buy
Price Target: $11.24
Current: $1.63
Upside: +589.37%
Veru Inc.
May 14, 2026
Rated: Buy
Price Target: $25
Current: $2.31
Upside: +982.25%
Pliant Therapeutics
May 12, 2026
Maintained: Hold
Price Target: $3
Current: $1.09
Upside: +175.23%
May 12, 2026
Maintained: Buy
Price Target: $49
Current: $7.76
Upside: +531.85%
May 8, 2026
Maintained: Buy
Price Target: $62
Current: $38.17
Upside: +62.43%
May 8, 2026
Reiterated: Buy
Price Target: $101
Current: $50.59
Upside: +99.64%
May 7, 2026
Maintained: Buy
Price Target: $587 → $578
Current: $536.86
Upside: +7.66%
Apr 29, 2026
Rated: Buy
Price Target: $62 → $64
Current: $61.98
Upside: +3.26%
Apr 2, 2026
Maintained: Buy
Price Target: $20
Current: $4.40
Upside: +354.55%
Oct 2, 2024
Maintained: Buy
Price Target: $9
Current: $4.83
Upside: n/a
May 17, 2023
Maintained: Hold
Price Target: $2
Current: $4.00
Upside: n/a
Aug 8, 2022
Downgraded: Hold
Price Target: $5 → $15
Current: $0.5113
Upside: n/a
Jul 29, 2022
Downgraded: Hold
Price Target: $12 → $1
Current: $0.000001
Upside: n/a
May 18, 2021
Maintained: Buy
Price Target: $25
Current: $4.09
Upside: n/a
Aug 9, 2019
Maintained: Buy
Price Target: $9 → $11
Current: $31.49
Upside: n/a
Jun 5, 2019
Downgraded: Hold
Price Target: $5
Current: $2.01
Upside: n/a
May 20, 2019
Maintained: Buy
Price Target: $60 → $39
Current: $6.13
Upside: n/a
Feb 27, 2019
Reiterated: Buy
Price Target: $176
Current: $17.96
Upside: n/a
Feb 26, 2019
Maintained: Buy
Price Target: $48 → $64
Current: $41.52
Upside: n/a
Feb 25, 2019
Maintained: Buy
Price Target: $126 → $117
Current: $58.64
Upside: n/a
Jan 23, 2019
Maintained: Buy
Price Target: $54 → $71
Current: $32.03
Upside: n/a
Sep 24, 2018
Maintained: Buy
Price Target: $156
Current: $62.51
Upside: n/a
Sep 17, 2018
Maintained: Buy
Price Target: $132
Current: $859.43
Upside: n/a
Jun 27, 2018
Downgraded: Hold
Price Target: $22 → $4
Current: $15.47
Upside: n/a
Jun 25, 2018
Initiated Coverage: Buy
Price Target: $26
Current: $11.26
Upside: n/a
May 16, 2018
Maintained: Buy
Price Target: $26 → $23
Current: $7.06
Upside: n/a
Sep 18, 2017
Maintained: Buy
Price Target: $24
Current: $0.0001
Upside: n/a
May 16, 2017
Reiterated: Hold
Price Target: $1 → $2
Current: $0.0001
Upside: n/a
May 5, 2017
Reiterated: Hold
Price Target: $3 → $6
Current: $3.72
Upside: n/a
Mar 7, 2017
Reiterated: Hold
Price Target: $9
Current: $14.69
Upside: n/a
Sep 4, 2014
Downgraded: Hold
Price Target: $14 → $11
Current: $3.98
Upside: n/a
Jun 17, 2013
Initiated Coverage: Buy
Price Target: n/a
Current: $0.08
Upside: n/a
May 3, 2013
Downgraded: Sell
Price Target: n/a
Current: $13.14
Upside: n/a
Jan 28, 2013
Initiated Coverage: Buy
Price Target: n/a
Current: $25.49
Upside: n/a